Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole- resistant isolate of Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1504-1507

  Oakley, K L ^a,b   Morrissey, G ^b   Denning, D W ^a,b,c  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [4 [4 [[5 (2,4 DIFLUOROPHENYL)TETRAHYDRO 5 (1H 1,2,4 TRIAZOL 1 YLMETHYL)FURAN 3 YL]METHOXY]PHENYL] 1 PIPERAZINYL] PHENYL] 2,4 DIHYDRO 2 (1 ETHYL 2 HYDROXYPROPYL) 3H 1,2,4 TRIAZOLE 3 ONE; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; CROSS RESISTANCE; DRUG BLOOD LEVEL; DRUG EFFICACY; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030845020     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1504     Document Type: Article

References (12)

1. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev. Infect. Dis. 12:1147-1201.
2. Denning, D. W., D. E. Stepan, K. G. Blume, and D. A. Stevens. 1992. Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient. J. Infect. 24:73-79.
3. Denning, D. W., L. Hall, M. Jackson, and S. Hollis. 1995. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob. Agents Chemother. 39:1809-1814.
4. Denning, D. W., K. Venkateswarlu, K. L. Oakley, M. J. Anderson, N. J. Manning, D. A. Stevens, D. W. Warnock, and S. L. Kelly. 1997. Itraconazole resistance in Aspergillus fumigatus. Antimicrob. Agents Chemother. 41:1364-1368.
5. Fothergill, A. W., D. A. Sutton, and M. G. Rinaldi. 1996. An in vitro head-to-head comparison of Schering 56592, amphotericin B, fluconazole, and itraconazole against a spectrum of filamentous fungi, abstr. F89, p. 115. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
6. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the post-mortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23-32.
7. Hosteller, J. S., L. H. Hanson, and D. A. Stevens. 1992. Effect of cyclodextrin on the pharmacology of antifungal oral azoles. Antimicrob. Agents Chemother. 33:1391-1392.
8. Khoo, S. H., and D. W. Denning. 1994. Invasive aspergillosis in patients with AIDS. Clin. Infect. Dis. 19:S41-S48.
9. Law, D., and D. W. Denning. 1996. In vitro activity of Schering 56592, compared with fluconazole and itraconazole against Candida spp., abstr. F88, p. 115. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Oakley, K. L., C. B. Moore, and D. W. Denning. 1997. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. Antimicrob. Agents Chemother. 41:1124-1126.
11. Perfect, J. R., G. M. Cox, R. K. Dodge, and W. A. Schell. 1996. In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob. Agents Chemother. 40:1910-1913.
12. Pfaller, M. A., L. Zerva, S. Messer, and R. Jones. 1996. Antifungal activity of a new triazole, SCH 56592, compared with four other antifungal agents tested against clinical isolates of Candida spp., abstr. F87, p. 115. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.